Human Breast Cell MDA-MB-468-based Proliferation Assay Service
Creative Biolabs has launched a proliferation assay based on human breast cell MDA-MB-468, which evaluates the effect of the sample to be tested on cell proliferation by treating MDA-MB-468 cells with various compounds or conditions.
MDA-MB-468 Cell
MDA-MB-468 is a human breast cancer cell line that is commonly used in cancer research. These cells are triple-negative breast cancer cells, meaning they lack estrogen, progesterone, and HER2 receptors, making them particularly aggressive and difficult to treat. MDA-MB-468 cells are commonly used to study the mechanisms of breast cancer development, progression, and response to treatment. They have been used in research investigating novel therapeutic approaches, drug sensitivity testing, and genetic studies aimed at identifying potential therapeutic targets for breast cancer.
MDA-MB-468-based Proliferation Assay at Creative Biolabs
Our Human Breast Cell MDA-MB-468-based Proliferation Assay service is specifically tailored for human breast cells. This assay provides a reliable and sensitive method to study the proliferation of MDA-MB-468 tumor cells.
-
Key features
1. Luminescent detection method that offers high sensitivity and a wide dynamic range for quantification of cell proliferation.
2. Customizable assay protocols to meet your specific research needs.
3. Experienced scientists who will perform the assay in a timely and efficient manner.
4. Creative Biolabs ultimately provides detailed reports, comprehensive data analysis, and interpretation.
Assay Information
Assay Procedure
How Our Service Can Assist Your Project
-
High-throughput screening
The MDA-MB-468-based proliferation assay service can help in screening a large number of compounds or drugs to identify potential candidates for breast cancer treatment.
The assay can be used to investigate the mechanisms underlying the proliferation of human breast cells, providing valuable insights into the biology of breast cancer.
By testing the efficacy of potential anti-cancer drugs on MDA-MB-468 cells, the assay can aid in the development of new treatment options.
The assay can also be used to identify potential biomarkers for breast cancer progression or drug response, leading to the development of new diagnostic tools and personalized treatment strategies.
Frequently Asked Questions
Q1: Why use MDA-MB-468 cells for the proliferation assay?
A1: MDA-MB-468 cells are commonly used for proliferation assays because they are a well-established and widely studied model cell line for breast cancer research. Because these cells are triple-negative, they do not express estrogen receptor (ER), progesterone receptor (PR), or human epidermal growth factor receptor 2 (HER2), which makes them particularly suitable for studying aggressive and difficult-to-treat breast cancer. Additionally, MDA-MB-468 cells have a high proliferation rate, making them ideal for studying cell growth and proliferation in vitro. They are also easily cultured in the laboratory and have been shown to exhibit consistent and reproducible results in proliferation assays.
Contact Us
To learn more about our Human Breast Cell MDA-MB-468-based Proliferation Assay, please contact us for a consultation.
For Research Use Only | Not For Clinical Use
Download our brochure